Insiders Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
25.07 ^USD	+2.49%		+3.72%	-15.07%

Apr. 17	Stifel Initiates Mirum Pharmaceuticals With Buy Rating, $48 Price Target	MT
Apr. 02	Mirum Pharmaceuticals, Inc. receives Positive Reimbursement Recommendation for Livmarli (Maralixibat Oral Solution) by Canada?S Cadth for Patients with Cholestatic Pruritus in Alagille Syndrome	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mirum Pharmaceuticals, Inc. Announces Management Changes	Jan. 16	CI
Mirum Pharmaceuticals Names Joanne Quan as Chief Medical Officer	Jan. 16	MT
Mirum Pharmaceuticals, Inc. Announces Management Appointments	Jan. 16	CI
Mirum Pharmaceuticals Insider Bought Shares Worth $256,791, According to a Recent SEC Filing	23-09-13	MT
Mirum Pharmaceuticals, Inc. Appoints Eric Bjerkholt as the Chief Financial Officer	23-09-11	CI
Mirum Pharmaceuticals Appoints Eric Bjerkholt as Finance Chief	23-09-11	MT
Insider Buy: Mirum Pharmaceuticals	23-09-05	MT
Insider Sell: Mirum Pharmaceuticals	23-05-05	MT
Mirum Pharmaceuticals, Inc. Announces Board Changes	23-04-06	CI
Mirum Pharmaceuticals, Inc. Announces Resignation of Ian Clements as Chief Financial Officer	23-01-09	CI
Mirum Pharmaceuticals, Inc. Announces Resignation of Carol L. Brosgart, M.D. as A Director of the Company and as A Member of the Nominating and Corporate Governance Committee of the Board, Effective December 19, 2022	22-12-19	CI
Mirum Pharmaceuticals, Inc. Appoints Lon Cardon to Board of Directors	22-12-19	CI
Insider Sell: Mirum Pharmaceuticals	22-11-16	MT
Mirum Pharmaceuticals, Inc. Announces Resignation of Edward T. Mathers as A Member of the Compensation Committee of the Board, Effective September 1, 2022	22-09-02	CI
Mirum Pharmaceuticals, Inc. Appoints Saira Ramasastry to the Board of Directors and as A Member of the Audit Committee	22-06-06	CI
Insider Buy: Mirum Pharmaceuticals	21-11-30	MT
Mirum Pharmaceuticals, Inc. Announces Board Changes	21-08-19	CI
Mirum Pharmaceuticals, Inc. Appoints Carol L. Brosgart, M.D. to Board of Directors	21-06-07	CI
Mirum Pharmaceuticals Appoints Peter Radovich as Chief Operating Officer	20-04-28	CI
Mirum Pharmaceuticals, Inc. Announces Resignation of Michael Grey as Executive Officer, Effective from January 1, 2020	19-12-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Mirum Pharmaceuticals, Inc.

Equities

MIRM

US6047491013

Insiders

Filters